CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Derma Sciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Derma Sciences Inc
214 Carnegie Ctr Ste 300
Phone: (609) 514-4744p:609 514-4744 PRINCETON, NJ  08540-6237  United States

This company was Merged or Acquired on 2/24/2017.
This company ceased filing statements with the SEC on 3/7/2017.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Derma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company's traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201612/31/2015YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Interim Executive Chairman of the Board, Principal Executive Officer Stephen T.Wills 58 12/21/2015 7/1/1997
Chief Financial Officer, Executive Vice President - Finance John E.Yetter 62 1/1/2013 8/28/2000
Group President - Traditional Wound Care and Corporate Accounts Robert C.Cole 62 1/1/2013 1/1/2003
6 additional Officers and Directors records available in full report.

Business Names
Business Name
BioD, LLC
BioDLogics, LLC
Derma First Aid Products
6 additional Business Names available in full report.

General Information
Stock Exchange: NASD
Federal Tax Id: 232328753
Email Address: info@dermasciences.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023